Published in J Urol on December 01, 2006
Testicular Vasculitis: A Sonographic and Pathologic Diagnosis. Case Rep Radiol (2017) 0.75
FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development (2010) 1.86
Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer (2004) 1.85
Osteosarcoma. J Am Acad Orthop Surg (2009) 1.73
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416. Clin Cancer Res (2005) 1.66
Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol (2008) 1.64
Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res (2005) 1.63
Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol (2009) 1.63
Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst (2009) 1.59
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol (2011) 1.59
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia (2004) 1.56
Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma. Gynecol Oncol (2009) 1.45
Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer (2004) 1.45
Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res (2004) 1.45
Leiomyoma of the urethra and bladder. J Urol (2007) 1.44
Intestinal metaplasia of the bladder. J Urol (2006) 1.41
Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. J Urol (2002) 1.40
Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (2011) 1.39
Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. Arch Pathol Lab Med (2008) 1.33
Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol (2010) 1.33
Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res (2007) 1.32
Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol (2009) 1.24
HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem (2010) 1.24
Inflammatory myofibroblastic tumors of the genitourinary tract--single entity or continuum? J Urol (2008) 1.22
Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol (2005) 1.21
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol (2010) 1.19
Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases. Hum Pathol (2008) 1.19
Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res (2005) 1.19
Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol (2005) 1.19
Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol (2003) 1.15
Large cell calcifying Sertoli cell tumor of testis. J Urol (2007) 1.13
Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol (2007) 1.13
Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol (2011) 1.11
Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res (2007) 1.09
Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res (2008) 1.08
Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res (2007) 1.08
Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer (2003) 1.07
Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. Hum Pathol (2007) 1.07
Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. Hum Pathol (2008) 1.05
Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol (2006) 1.05
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol (2008) 1.05
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol (2007) 1.05
Molecular imaging of NF-kappaB in prostate tissue after systemic administration of IL-1 beta. Prostate (2008) 1.04
Xanthogranulomatous sialadenitis: a case report and literature review. Ear Nose Throat J (2005) 1.01
Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences. Diagn Cytopathol (2012) 1.00
Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB J (2005) 1.00
Primary testicular lymphoma. J Urol (2007) 0.99
Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. PLoS One (2013) 0.99
Tumoral calcinosis in the cervical spine in a patient with CREST syndrome. A case report. J Bone Joint Surg Am (2006) 0.98
Radiation cystitis. J Urol (2009) 0.98
Small cell carcinoma of the urinary bladder. Histol Histopathol (2010) 0.97
Laser-assisted microdissection in translational research: theory, technical considerations, and future applications. Appl Immunohistochem Mol Morphol (2013) 0.97
Adenomatoid tumor of the adrenal gland. J Urol (2008) 0.97
Fine needle aspiration cytology of breast cylindroma in a woman with familial cylindromatosis: a case report. Acta Cytol (2004) 0.97
Prostatic leiomyoma with atypia: follow-up study of 10 cases. Ann Diagn Pathol (2008) 0.97
Phyllodes tumor of the prostate. J Urol (2005) 0.96
Squamous cell carcinoma of the renal pelvis. J Urol (2010) 0.96
Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res (2008) 0.95
The P2X7 receptor: a novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomarkers Prev (2006) 0.95
Endometriosis of the ureter. J Urol (2008) 0.94
Carcinoid tumor of the kidney. J Urol (2008) 0.94
Mucinous tubular and spindle cell carcinoma of the kidney. J Urol (2009) 0.94
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin. Clin Cancer Res (2007) 0.94
Sarcomatoid urothelial carcinoma of the renal pelvis. J Urol (2006) 0.94
Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis. Prostate (2008) 0.93
Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol (2007) 0.93
Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation. Prostate (2009) 0.93
Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model. Pharm Res (2011) 0.92
Soft tissue tumors of the penis: a review. Anal Quant Cytol Histol (2006) 0.92
c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol (2005) 0.92
Sarcoidosis of the testis and epididymis. J Urol (2008) 0.91
Small cell carcinoma of the urinary bladder--histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Appl Immunohistochem Mol Morphol (2007) 0.91
FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations. Mod Pathol (2009) 0.91
Benign soft tissue tumors of the testis. J Urol (2009) 0.91
Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear. Acta Cytol (2002) 0.91
Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers. Int J Gynecol Cancer (2012) 0.91
Ganglioneuroma of the adrenal gland. J Urol (2009) 0.90
Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology (2002) 0.90
The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. Future Oncol (2011) 0.90
The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther (2011) 0.89
Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer (2013) 0.89
Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer (2002) 0.89
Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. Urol Oncol (2010) 0.89
Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology (2011) 0.89
MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer. Hum Pathol (2013) 0.88
Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma. Clin Cancer Res (2006) 0.87
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. J Transl Med (2012) 0.87
Low-dose-rate brachytherapy for treatment of uterine didelphys malignancy. J Clin Oncol (2010) 0.87
18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response. Int J Gynecol Cancer (2011) 0.87
Renal medullary carcinoma. J Urol (2005) 0.87
Renal epithelioid angiomyolipoma. J Urol (2009) 0.86
Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study. J Oncol (2009) 0.86
Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. Am J Pathol (2009) 0.85
Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol (2012) 0.85
The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol (2002) 0.85
Primary melanoma of the bladder. J Urol (2011) 0.85
Cyclin E as molecular marker in the management of breast cancer: a review. Anal Quant Cytol Histol (2006) 0.85
Retroperitoneal liposarcoma. J Urol (2007) 0.84
Quantitative evaluation of 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation. Mol Imaging Biol (2007) 0.84